Health European Medicines Agency Awards Orphan Drug Status to Pegtarazimod The European Medicines Agency (EMA) has awarded orphan drug designation (ODD) to pegtarazimod (RLS-0071) for the treatment of patients suffering from graft-vs-host disease (GVHD).... Editorial8 hours ago